Robert B. Den, MD
Room G-301, Bodine Center
Philadelphia, PA 19107
(215) 955-0412 fax
Most Recent Peer-reviewed Publications
- Evaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysis
- Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy
- Novel actions of next-generation taxanes benefit advanced stages of prostate cancer
- Uncertainties encountered in implementation of adaptive planning with in vivo dosimeters
- Is robotic arm stereotactic body radiation therapy 'virtual high-dose rate brachytherapy' effective for prostate cancer? An analysis of comparative effectiveness using published data
Harvard Medical School, Boston, MA
Radiation Oncology, Thomas Jefferson University, Philadelphia, PA
Assistant Professor, Department of Cancer Biology (2012)
Research and Clinical Interests
I am a board-certified radiation oncologist who specializes in the treatment of prostate cancer. I see patients and discuss their cases in a genitourinary multidisciplinary clinic with colleagues in urology and medical oncology. I specialize in using IMRT to treat men with prostate cancer to improve patients outcomes and decrease the side effects of treatment.
I am also a translational researcher with a laboratory at Jefferson that focuses on combining new biologic agents with radiation therapy. The goal of this work is to introduce the most exciting compounds into clinical trials to benefit my patients.